Optimization of Radiation Protection Through Genomic Analyses

Launched by UNIVERSITY HOSPITAL, ESSEN · Feb 7, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how our genes respond to radiation exposure, particularly in people with thoracic (chest) or head and neck cancers. Researchers are using advanced technology to analyze genetic material to identify specific changes that can help understand how much radiation a person has been exposed to, the type of radiation, and how well their body can repair itself after exposure. The ultimate aim is to find ways to protect patients better during treatments that involve radiation.

To participate in this trial, you need to be between the ages of 65 and 74 and have been diagnosed with thoracic or head and neck cancer, but you should not have had any previous cancer treatments or diagnoses. If you qualify, you can expect to undergo genetic testing, which will help researchers gather important information about your individual response to radiation. This study is currently looking for participants, and it could play a vital role in improving radiation protection for future cancer treatments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ECOG 0/1 no prior treatment no prior cancer diagnosis thoracic or head and neck cancer
• Exclusion Criteria:
• • prior treatment (chemotherapy, radiotherapy, etc.) prior cancer diagnosis